Issue Information

Issue Information
Pubblicazione: (2024)

Issue Information
Pubblicazione: (2026)

Profiling the needs of dementia caregivers in a Brazilian cross‐sectional study
di: Alan Cronemberger Andrade, et al.
Pubblicazione: (2025)

Clinically meaningful outcomes in Alzheimer's disease and Alzheimer's disease related dementias trials
di: Luke E. Stoeckel, et al.
Pubblicazione: (2025)

Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment
di: Chao‐Yi Wu, et al.
Pubblicazione: (2025)

Development and classification accuracy of an automated cognitive screening tool combining working memory and connected speech tasks for early detection of cognitive impairment in primary care
di: Robin C. Hilsabeck, et al.
Pubblicazione: (2025)

Understanding the impact of amyloid beta targeted therapies on biomarkers and clinical endpoints in Alzheimer's disease
di: Ronald C. Petersen, et al.
Pubblicazione: (2025)

Perspective: Minimal clinically important difference (MCID) and Alzheimer's disease clinical trials
di: Jeffrey Cummings
Pubblicazione: (2025)

Diabetes mellitus exacerbates changes in white matter hyperintensity shapes and volume: A longitudinal study
di: Shihao Xu, et al.
Pubblicazione: (2025)

Cardiorespiratory fitness modifies the relationship between arterial stiffness and cerebral blood flow independent of physical activity
di: Brianne M. Breidenbach, et al.
Pubblicazione: (2025)

Vestibular‐related dizziness duration and cognitive deficits in older adults
di: Xiaobao Ma, et al.
Pubblicazione: (2025)

First‐in‐human positron emission tomography study of intranasal insulin in aging and MCI
di: Kiran K. Solingapuram Sai, et al.
Pubblicazione: (2025)

AI approaches for phenotyping Alzheimer's disease and related dementias using electronic health records
di: Sara Knox, et al.
Pubblicazione: (2025)

The impact of estimated cardiorespiratory fitness on Alzheimer's disease biomarkers and their relationships with cognitive decline
di: Adam J Paulsen, et al.
Pubblicazione: (2025)

Comparison of sample characteristics of Wisconsin Alzheimer's Disease Research Center participants with the Wisconsin state population—An evaluation of the recruitment effort
di: Yue Ma, et al.
Pubblicazione: (2025)

Physical activity as a resistance or resilience mechanism in Down syndrome Alzheimer's disease
di: Victoria L. Fleming, et al.
Pubblicazione: (2025)

The plasma p‐tau217/BD‐tau ratio improves biomarker short‐term variability in memory clinic patients
di: Frederikke Kragh Clemmensen, et al.
Pubblicazione: (2025)

Statin use and dementia risk: A systematic review and updated meta‐analysis
di: Fernando Luiz Westphal Filho, et al.
Pubblicazione: (2025)

Clinical efficacy of anti‐amyloid antibodies in apolipoprotein E ε4 homozygotes: A Bayesian reanalysis of lecanemab and donanemab phase 3 results
di: Stefan Teipel, et al.
Pubblicazione: (2025)

Uncovering barriers to early diagnosis of Alzheimer's disease: a European perspective
di: David A. Pérez‐Martínez, et al.
Pubblicazione: (2025)

Person‐centered care at population scale: The Swedish registry for behavioral and psychological symptoms of dementia
di: Linus Jönsson, et al.
Pubblicazione: (2025)

Data‐driven discovery of associations between prescribed drugs and dementia risk: A systematic review
di: Benjamin R. Underwood, et al.
Pubblicazione: (2025)

A common outcome set for trials in dementia with Lewy bodies (DLB COS)
di: Joseph P. M. Kane, et al.
Pubblicazione: (2025)

Blood‐based biomarker prescreening with different testing combinations and cutoffs: A simulation study examining efficacy and cost‐effectiveness in Alzheimer's disease prevention studies
di: Kenichiro Sato, et al.
Pubblicazione: (2025)

Perspectives on meaningful dementia treatment and care from those with lived experience
di: Walter Moczygemba, et al.
Pubblicazione: (2025)

Measuring time saved in Alzheimer's disease: What is a meaningful slowing of progression?
di: Krista Lanctot, et al.
Pubblicazione: (2025)

Why testing and diagnosis for Alzheimer's disease are mission critical
di: Brent W. Beasley
Pubblicazione: (2025)

Directionality between cognitive function and daily physical activity patterns
di: Francesca R. Marino, et al.
Pubblicazione: (2025)

Physical activity modifies associations between cerebrospinal fluid tau measures and executive function
di: Ryan J. Dougherty, et al.
Pubblicazione: (2025)

Potential of low‐field MRI for increasing participation of Filipino Americans and underrepresented populations in Alzheimer's and dementia research
di: Mikkael Lamoca, et al.
Pubblicazione: (2025)

Care staff perspectives of clinically meaningful outcomes for dementia residents
di: Alaine E. Reschke‐Hernández, et al.
Pubblicazione: (2025)

Time saved in activities of daily living and whole‐brain volume: Post hoc analysis of a randomized feasibility trial of gamma oscillation treatment in participants with mild or moderate Alzheimer's disease
di: Ralph Kern, et al.
Pubblicazione: (2025)

ACE trial design: Equol targeting estrogen receptor‐β in vascular and cognitive aging
di: Akira Sekikawa, et al.
Pubblicazione: (2025)

Activity variability: A novel physical activity metric and its association with cognitive impairment
di: Patrick T. Donahue, et al.
Pubblicazione: (2025)

What is older adults’ understanding of Alzheimer's disease research registries? Findings from 20 focus group studies
di: Litty Samuel, et al.
Pubblicazione: (2025)

Simulation of Alzheimer's diagnostic flows with blood biomarker test options in Japan
di: Ataru Igarashi, et al.
Pubblicazione: (2025)